Researchers have identified a molecular mechanism linking Epstein-Barr virus (EBV) infection to multiple sclerosis, a finding that emerges from analysis of how the virus alters gene expression and cellular signaling in immune cells.

The study examined how EBV disrupts normal cellular processes that typically protect the nervous system from autoimmune attack. The virus appears to trigger changes in gene expression patterns within infected cells, leading to abnormal immune signaling that causes the body's immune system to mistakenly target myelin, the protective coating around nerve fibers. This misguided immune response defines MS.

EBV is extremely common, infecting approximately 95 percent of the global population. Yet only a small fraction of infected individuals develop MS, suggesting that the virus alone does not cause the disease. Instead, researchers propose that EBV infection combined with genetic susceptibility and potentially other environmental factors converges to trigger MS development.

The research builds on earlier epidemiological evidence showing a strong association between EBV infection and MS risk. A 2022 study published in Science found that nearly all MS patients had been infected with EBV, strengthening the viral hypothesis of MS etiology. This latest work goes deeper, mapping the specific cellular and molecular pathways through which viral infection drives autoimmunity.

Understanding these mechanisms holds practical value for MS management and prevention. If researchers can identify which infected individuals face highest MS risk, interventions targeting EBV or its downstream cellular effects might prevent disease development in vulnerable populations. Early EBV treatment or targeted immunotherapies could eventually reduce MS incidence.

The findings also inform ongoing clinical trials testing antiviral approaches in MS patients. Existing MS treatments largely suppress immune function broadly. A virus-specific strategy could offer more targeted therapeutic options with fewer side effects.

However, scientists emphasize that EBV infection remains necessary but not sufficient for MS.